407 related articles for article (PubMed ID: 26213384)
41. Deletion of alpha-neurexins does not cause a major impairment of axonal pathfinding or synapse formation.
Dudanova I; Tabuchi K; Rohlmann A; Südhof TC; Missler M
J Comp Neurol; 2007 May; 502(2):261-74. PubMed ID: 17347997
[TBL] [Abstract][Full Text] [Related]
42. Loss of Synapse Repressor MDGA1 Enhances Perisomatic Inhibition, Confers Resistance to Network Excitation, and Impairs Cognitive Function.
Connor SA; Ammendrup-Johnsen I; Kishimoto Y; Karimi Tari P; Cvetkovska V; Harada T; Ojima D; Yamamoto T; Wang YT; Craig AM
Cell Rep; 2017 Dec; 21(13):3637-3645. PubMed ID: 29281813
[TBL] [Abstract][Full Text] [Related]
43. Postsynaptic origin of CB1-dependent tonic inhibition of GABA release at cholecystokinin-positive basket cell to pyramidal cell synapses in the CA1 region of the rat hippocampus.
Neu A; Földy C; Soltesz I
J Physiol; 2007 Jan; 578(Pt 1):233-47. PubMed ID: 17053036
[TBL] [Abstract][Full Text] [Related]
44. The soluble neurexin-1β ectodomain causes calcium influx and augments dendritic outgrowth and synaptic transmission.
Wierda KDB; Toft-Bertelsen TL; Gøtzsche CR; Pedersen E; Korshunova I; Nielsen J; Bang ML; Kønig AB; Owczarek S; Gjørlund MD; Schupp M; Bock E; Sørensen JB
Sci Rep; 2020 Oct; 10(1):18041. PubMed ID: 33093500
[TBL] [Abstract][Full Text] [Related]
45. Neurexin-2 restricts synapse numbers and restrains the presynaptic release probability by an alternative splicing-dependent mechanism.
Lin PY; Chen LY; Zhou P; Lee SJ; Trotter JH; Südhof TC
Proc Natl Acad Sci U S A; 2023 Mar; 120(13):e2300363120. PubMed ID: 36961922
[TBL] [Abstract][Full Text] [Related]
46. Synaptic Neurexin Complexes: A Molecular Code for the Logic of Neural Circuits.
Südhof TC
Cell; 2017 Nov; 171(4):745-769. PubMed ID: 29100073
[TBL] [Abstract][Full Text] [Related]
47. Endocannabinoid signaling in the brain.
Wilson RI; Nicoll RA
Science; 2002 Apr; 296(5568):678-82. PubMed ID: 11976437
[TBL] [Abstract][Full Text] [Related]
48. Crystal Structure of an Engineered LRRTM2 Synaptic Adhesion Molecule and a Model for Neurexin Binding.
Paatero A; Rosti K; Shkumatov AV; Sele C; Brunello C; Kysenius K; Singha P; Jokinen V; Huttunen H; Kajander T
Biochemistry; 2016 Feb; 55(6):914-26. PubMed ID: 26785044
[TBL] [Abstract][Full Text] [Related]
49. Capabilities of neurexins in the chick ciliary ganglion.
Ross BS; Conroy WG
Dev Neurobiol; 2008 Feb; 68(3):409-19. PubMed ID: 18161851
[TBL] [Abstract][Full Text] [Related]
50. Postsynaptic endocannabinoid release is critical to long-term depression in the striatum.
Gerdeman GL; Ronesi J; Lovinger DM
Nat Neurosci; 2002 May; 5(5):446-51. PubMed ID: 11976704
[TBL] [Abstract][Full Text] [Related]
51. Opposite control of frontocortical 2-arachidonoylglycerol turnover rate by cannabinoid type-1 receptors located on glutamatergic neurons and on astrocytes.
Belluomo I; Matias I; Pernègre C; Marsicano G; Chaouloff F
J Neurochem; 2015 Apr; 133(1):26-37. PubMed ID: 25626460
[TBL] [Abstract][Full Text] [Related]
52. Endocannabinoid-mediated short-term suppression of excitatory synaptic transmission to medium spiny neurons in the striatum.
Narushima M; Hashimoto K; Kano M
Neurosci Res; 2006 Mar; 54(3):159-64. PubMed ID: 16413076
[TBL] [Abstract][Full Text] [Related]
53. Endocannabinoid Mediates Excitatory Synaptic Function of β-Neurexins. Commentary: β-Neurexins Control Neural Circuits by Regulating Synaptic Endocannabinoid Signaling.
Wang H
Front Neurosci; 2016; 10():203. PubMed ID: 27242408
[No Abstract] [Full Text] [Related]
54. Astrocytes Assemble Thalamocortical Synapses by Bridging NRX1α and NL1 via Hevin.
Singh SK; Stogsdill JA; Pulimood NS; Dingsdale H; Kim YH; Pilaz LJ; Kim IH; Manhaes AC; Rodrigues WS; Pamukcu A; Enustun E; Ertuz Z; Scheiffele P; Soderling SH; Silver DL; Ji RR; Medina AE; Eroglu C
Cell; 2016 Jan; 164(1-2):183-196. PubMed ID: 26771491
[TBL] [Abstract][Full Text] [Related]
55. Endogenous β-neurexins on axons and within synapses show regulated dynamic behavior.
Klatt O; Repetto D; Brockhaus J; Reissner C; El Khallouqi A; Rohlmann A; Heine M; Missler M
Cell Rep; 2021 Jun; 35(11):109266. PubMed ID: 34133920
[TBL] [Abstract][Full Text] [Related]
56. Endocannabinoid-mediated metaplasticity in the hippocampus.
Chevaleyre V; Castillo PE
Neuron; 2004 Sep; 43(6):871-81. PubMed ID: 15363397
[TBL] [Abstract][Full Text] [Related]
57. Neurexins cluster Ca
Luo F; Sclip A; Jiang M; Südhof TC
EMBO J; 2020 Apr; 39(7):e103208. PubMed ID: 32134527
[TBL] [Abstract][Full Text] [Related]
58. Developmental changes in retrograde messengers involved in depolarization-induced suppression of excitation at parallel fiber-Purkinje cell synapses in rodents.
Crepel F
J Neurophysiol; 2007 Jan; 97(1):824-36. PubMed ID: 17108093
[TBL] [Abstract][Full Text] [Related]
59. Synaptic strength as a function of post- versus presynaptic expression of the neural cell adhesion molecule NCAM.
Dityatev A; Dityateva G; Schachner M
Neuron; 2000 Apr; 26(1):207-17. PubMed ID: 10798405
[TBL] [Abstract][Full Text] [Related]
60. Endocannabinoids potentiate synaptic transmission through stimulation of astrocytes.
Navarrete M; Araque A
Neuron; 2010 Oct; 68(1):113-26. PubMed ID: 20920795
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
